Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
2801
DELISTED
ProAssurance
PRA
| $8.61M | ﹤0.01% |
378,451
-96,324
| -20% | -$2.43M |
|
2802
Rigel Pharmaceuticals
RIGL
$716M
| $8.61M | ﹤0.01% |
198,342
+37,487
| +23% | +$1.42M |
|
2803
Adeia
ADEA
$3.44B
| $8.59M | ﹤0.01% |
1,459,968
-338,541
| -19% | -$1.92M |
|
2804
iShares MSCI EAFE Growth ETF
EFG
$17B
| $8.59M | ﹤0.01% |
80,075
-32,706
| -29% | -$3.48M |
|
2805
PUT
ARK Web x.0 ETF
ARKW
$1.75B
| $8.58M | ﹤0.01% |
55,700
+37,600
| +208% | +$5.39M |
|
2806
Liberty Media Series A
FWONA
$22.2B
| $8.57M | ﹤0.01% |
209,912
+39,735
| +23% | +$1.54M |
|
2807
Armstrong World Industries
AWI
$7.74B
| $8.54M | ﹤0.01% |
79,646
+2,733
| +4% | +$281K |
|
2808
CALL
Eli Lilly
LLY
$995B
| $8.54M | ﹤0.01% |
37,200
-90,800
| -71% | -$18.2M |
|
|
CLAA
2809
DELISTED
Colonnade Acquisition Corp. II
CLAA
| $8.53M | ﹤0.01% |
+873,825
| New | +$8.56M |
|
|
SRG
2810
Seritage Growth Properties
SRG
$137M
| $8.52M | ﹤0.01% |
462,924
-9,012
| -2% | -$160K |
|
2811
Lands' End
LE
$395M
| $8.51M | ﹤0.01% |
207,265
+176,051
| +564% | +$4.81M |
|
2812
iShares Global Energy ETF
IXC
$2.8B
| $8.51M | ﹤0.01% |
319,911
+20,630
| +7% | +$536K |
|
2813
B&G Foods
BGS
$289M
| $8.49M | ﹤0.01% |
258,880
-13,687
| -5% | -$422K |
|
2814
PUT
iShares Global Clean Energy ETF
ICLN
$2.41B
| $8.49M | ﹤0.01% |
361,900
+186,900
| +107% | +$4.27M |
|
2815
WisdomTree US Multifactor Fund
USMF
$305M
| $8.48M | ﹤0.01% |
215,789
| – | – |
|
2816
TFS Financial
TFSL
$5.22B
| $8.47M | ﹤0.01% |
417,208
-33,892
| -8% | -$705K |
|
|
EGRX
2817
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $8.46M | ﹤0.01% |
197,762
+60,540
| +44% | +$2.5M |
|
2818
Broadstone Net Lease
BNL
$4.06B
| $8.46M | ﹤0.01% |
361,486
+227,641
| +170% | +$4.89M |
|
|
SJR
2819
DELISTED
Shaw Communications Inc.
SJR
| $8.45M | ﹤0.01% |
292,319
-35,422
| -11% | -$1.02M |
|
2820
CALL
Canadian National Railway
CNI
$77B
| $8.44M | ﹤0.01% |
+80,000
| New | +$8.83M |
|
|
PETQ
2821
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $8.44M | ﹤0.01% |
218,699
+160,438
| +275% | +$6.4M |
|
2822
Alkami Technology
ALKT
$2.02B
| $8.44M | ﹤0.01% |
+236,608
| New | +$8.67M |
|
|
LENZ
2823
LENZ Therapeutics
LENZ
$158M
| $8.43M | ﹤0.01% |
+39,204
| New | +$6.83M |
|
2824
PUT
Thermo Fisher Scientific
TMO
$209B
| $8.43M | ﹤0.01% |
16,700
+1,100
| +7% | +$519K |
|
2825
HUTCHMED
HCM
$2.01B
| $8.4M | ﹤0.01% |
214,032
-39,288
| -16% | -$1.13M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.